NextSource Pharma

NextSource Biotechnology is a specialty pharmaceutical company that focuses on the acquisition, manufacture, and commercialization of niche and sole-source pharmaceutical products. The company is best known for its management of Gleostine (lomustine), a critical chemotherapy agent used in the treatment of brain tumors and Hodgkin lymphoma. NextSource specializes in maintaining the supply chain for essential medications that may be overlooked by larger pharmaceutical firms. Their business model centers on optimizing the lifecycle of established therapeutic agents to ensure continued patient access to life-saving treatments. The company operates primarily within the oncology space, providing specialized distribution and support services for its product portfolio.